XM does not provide services to residents of the United States of America.
A
A

Amgen


News

Amid an uncertain landscape, high quality may offer stable ground

LIVE MARKETS-Amid an uncertain landscape, high quality may offer stable ground Dow and S&P 500 climb, Nasdaq off ~0.2% Financials lead S&P 500 sector gainers; Comm Svcs weakest group Euro STOXX 600 index up ~0.5% Dollar slips; gold, crude both off ~1%; bitcoin off >2% U.S. 10-Year Treasury yield dips to ~3.82% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters.
A
G
K
N
V
G
U
U
F
I
S
U
A
G
B

Amgen sues Samsung biotech unit over bone drug copies

Amgen sues Samsung biotech unit over bone drug copies By Blake Brittain Aug 13 (Reuters) - Amgen AMGN.O has sued Samsung's biologics unit 207940.KS in New Jersey federal court over its proposed biosimilar versions of Amgen's blockbuster bone drugs Prolia and Xgeva. Amgen's lawsuit against Samsung Bioepis, filed on Monday, said the biosimilars would infringe 34 patents covering Amgen drugs.
A

Amgen To Open New Site In Hyderabad, India

BRIEF-Amgen To Open New Site In Hyderabad, India Aug 9 (Reuters) - Amgen Inc AMGN.O : AMGEN TO OPEN NEW SITE IN HYDERABAD, INDIA Source text for Eikon: ID:nPreCsdBha Further company coverage: AMGN.O
A

Tech surge, BOJ's dovish comments boost Wall Street

US STOCKS-Tech surge, BOJ's dovish comments boost Wall Street For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps on FY revenue forecast raise Charles River slides after cutting FY forecasts Indexes up: S&P 500 1.36%, Nasdaq 1.64%, Dow 0.9% Updated at 11:22 a.m.
A
A
T
U
U
U
U
D

U.S. STOCKS Abbott Laboratories, Medtronic, Axon

BUZZ-U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes advanced on Wednesday, aided by a dovish turn by Japan's top policymaker after a surprise interest rate hike last week which partly sparked heavy volatility in global markets.
A
A
C
F
I
T
U
U
L

Wall St charges ahead as Big Tech relief rally continues

US STOCKS-Wall St charges ahead as Big Tech relief rally continues For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast Charles River slides after cutting FY forecasts Indexes up: S&P 500 1.2%, Nasdaq 1.7%, Dow 0.7% Updated at 9:35 a.m.
A
A
N
U
U
U
U
D

U.S. STOCKS Ralph Lauren, Illumina, Disney

BUZZ-U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, and cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
C
F
I
T
U
G
L
S
A

Wall St set to open higher as Big Tech buying continues

US STOCKS-Wall St set to open higher as Big Tech buying continues For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast CVS Health down after cutting FY profit forecast Futures up: S&P 500 1%, Nasdaq 1.18%, Dow 0.72% Updated at 8:25 a.m.
A
A
M
N
U
W
U
U
U
D

U.S. STOCKS Walt Disney, SpringWorks, Shopify

BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, with sentiment also getting a boost from cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
F
T
U
L
S

Futures advance as Big Tech continues to recover

US STOCKS-Futures advance as Big Tech continues to recover For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Airbnb slides after forecasting Q3 revenue below estimates Fortinet jumps after raising FY revenue forecast CVS Health down after cutting FY profit forecast Futures up: Dow 0.8%, S&P 1.2%, Nasdaq 1.5% Updated at 7:05 a.m.
A
A
M
N
U
W
U
U
U
D

Futures rally as Big Tech extends recovery

US STOCKS-Futures rally as Big Tech extends recovery For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Futures up: S&P 500 1.05%, Nasdaq 1.21%, Dow 0.79% Aug 7 (Reuters) - U.S. stock index futures jumped on Wednesday as risk appetite returned after a steep selloff earlier in the week, with sentiment also getting a boost from cautious comments on interest-rate hikes by an influential Bank of Japan policymaker.
A
B
U
U
U
U
D
A

Amgen falls as Q2 profit slips

BUZZ-Amgen falls as Q2 profit slips ** Drugmaker Amgen's AMGN.O shares fall 4% to $315.51 premarket ** Co late on Tuesday reported Q2 adjusted profit of $4.97 per share, largely in-line with average analyst estimate -LSEG data ** Adj. profit slipped 1% year-over-year hurt by higher expenses, including costs related to development of its experimenta
A

U.S. Amgen, Atkore, MoneyLion

U.S. RESEARCH ROUNDUP-Amgen, Atkore, MoneyLion Aug 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Atkore and MoneyLion on Wednesday. HIGHLIGHTS * Amgen Inc AMGN.O : RBC raises target price to $362 from $332 * Atkore Inc ATKR.N : RBC cuts to sector perform from outperform * MoneyLion ML.N : Needham cuts target price to $70 from $100 * Progyny Inc PGNY.O : BTIG cuts to neutral from buy * Truecar Inc TRUE.O :
A
A
A
B
B

Amgen Inc reports results for the quarter ended in June - Earnings Summary

Amgen Inc reports results for the quarter ended in June - Earnings Summary Amgen Inc AMGN.OQ reported quarterly adjusted earnings of $4.97​​ per share for the quarter ended in June, lower than the same quarter last year, when the company reported EPS of $5.00. The mean expectation of twenty two analysts for the quarter was for earnings of $5.01 per share.
A

Amgen falls on downbeat second-quarter profit

BUZZ-Amgen falls on downbeat second-quarter profit ** Shares of drugmaker Amgen AMGN.O fall ~1.8% to $322.99 in after-market trade ** AMGN reports Q2 adj. profit of $4.97/shr vs analysts' average est. of $5/shr - LSEG ** Says quarterly profit slipped 1% due to higher expenses ** Company's quarterly revenue of $8.39 bln beats analysts' average expectation of $8.37 bln ** AMGN raises the lower end of its 2024 revenue outlook to a range of $32.8 bln to $33.8 bln from a previous low end forecast of
A

Amgen quarterly profit slips, obesity data on track for late 2024

UPDATE 2-Amgen quarterly profit slips, obesity data on track for late 2024 Adds analyst comment paragraph 4, company comment paragraph 10; updates share price By Deena Beasley Aug 6 (Reuters) - Amgen AMGN.O on Tuesday said its second-quarter profit slipped 1% as higher expenses, including costs related to development of its experimental obesity drug MariTide, offset a 20% increase in revenue driven by the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics.
A

Amgen second quarter profit dips, sales rise 20%

Amgen second quarter profit dips, sales rise 20% By Deena Beasley Aug 6 (Reuters) - Amgen AMGN.O on Tuesday said its second-quarter profit slipped 1% as higher expenses offset a 20% increase in revenue driven by the biotechnology company's October acquisition of rare disease drugmaker Horizon Therapeutics. Amgen reported adjusted earnings of $4.97 per share, which was just short of the average analyst estimate of $5.00, according to LSEG data.
A

U.S. STOCKS IDEXX, Amgen, Airbnb

BUZZ-U.S. STOCKS ON THE MOVE-IDEXX, Amgen, Airbnb Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose over 1% on Tuesday, as investors looked for bargains after a global stock selloff and dovish comments from Federal Reserve officials lifted market sentiment.
A
A
B
I
U
U
F
M
R
U
V
M

PREVIEW: Amgen shares climb with results on tap

BUZZ-PREVIEW: Amgen shares climb with results on tap ** Amgen AMGN.O shares up 1.8% at $331.09 ahead of Q2 results due after the closing bell amid broad market recovery from three-day selloff ** The biotech company is expected to post EPS of $5.01 on revenue of $8.33 bln, per LSEG data, vs yr-ago results of $5.00 in EPS and $6.99 bln in revenue **
A
U

Rollercoaster markets, Nikkei rebounds 10%

MORNING BID AMERICAS-Rollercoaster markets, Nikkei rebounds 10% A look at the day ahead in U.S. and global markets from Mike Dolan The speed and scale of Tuesday's 10% Tokyo bounce after its worst day in 37 years suggests the wild global market swings of the past week are more rooted in speculative churn than economic fright. While that's only partly reassuring - as persistent market turbulence can itself sap economic activity - there's good reason to believe a slowing U.S.
A
C
N
U
W
J
U
U
U
F
F
D
I
J
M
S
B



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.